Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $707 at RBC Capital

May 18, 2026 5:14 AM
RBC Capital analyst Brian Abrahams lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $707.00 (from $762.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change